Academic Journal
Immune checkpoint molecules in solid organ transplantation: A promising way to prevent rejection.
| Title: | Immune checkpoint molecules in solid organ transplantation: A promising way to prevent rejection. |
|---|---|
| Authors: | Righi I; Thoracic Surgery and Lung Transplantation Unit, Department of Cardio- Thoracic - Vascular Disease, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy., Trabattoni D; Department of Biomedical and Clinical Sciences, University of Milan, Via Giovan Battista Grassi 74, 20157 Milan, Italy., Rosso L; Thoracic Surgery and Lung Transplantation Unit, Department of Cardio- Thoracic - Vascular Disease, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan Via Francesco Sforza 12, 20122, Milan, Italy., Vaira V; Department of Pathophysiology and Transplantation, University of Milan Via Francesco Sforza 12, 20122, Milan, Italy; Division of Pathology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy., Clerici M; Department of Pathophysiology and Transplantation, University of Milan Via Francesco Sforza 12, 20122, Milan, Italy; IRCCS Fondazione Don Carlo Gnocchi ONLUS, Via Capecelatro 66, 20148 Milan, Italy. Electronic address: mario.clerici@unimi.it. |
| Source: | Immunology letters [Immunol Lett] 2024 Jun; Vol. 267, pp. 106860. Date of Electronic Publication: 2024 Apr 25. |
| Abstract: | Immune checkpoint (IC) molecules modulate immune responses upon antigen presentation; the interaction between different IC molecules will result in the stimulation or, rather, the thwarting of such responses. Tumor cells express increased amounts of inhibitory IC molecules in an attempt to evade immune responses; therapeutic agents have been developed that bind inhibitory IC molecules, restoring tumor-directed immune responses and changing the prognosis of a number of cancers. Stimulation of inhibitory IC molecules could be beneficial in preventing rejection in the setting of solid organ transplantation (SOT), and in vivo as well as in vivo results obtained in animal models show this to indeed to be the case. With the exception of belatacept, a monoclonal antibody (mAb) in which an IgG Fc fragment is linked to the extracellular domain of CTLA-4, this has not yet translated into the generation of novel therapeutic approaches to prevent SOT rejection. We provide a review of state-of-the art knowledge on the role played by IC molecules in transplantation, confident that innovative research will lead to new avenues to manage rejection in solid organ transplant. Competing Interests: Declaration of competing interest The authors have no competing interests to declare. (Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.) |
| Publication Type: | Journal Article; Review |
| Language: | English |
| Journal Info: | Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7910006 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0542 (Electronic) Linking ISSN: 01652478 NLM ISO Abbreviation: Immunol Lett Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Amsterdam, Elsevier/North-Holland Biomedical Press. |
| MeSH Terms: | Graft Rejection*/immunology , Graft Rejection*/prevention & control , Organ Transplantation*/adverse effects , Immune Checkpoint Proteins*/metabolism , Immune Checkpoint Proteins*/genetics, Humans ; Animals ; Immune Checkpoint Inhibitors/therapeutic use ; Immune Checkpoint Inhibitors/pharmacology |
| Contributed Indexing: | Keywords: Immune checkpoint molecules; PD-1; Rejection; Therapy; Transplantation |
| Substance Nomenclature: | 0 (Immune Checkpoint Proteins) 0 (Immune Checkpoint Inhibitors) |
| Entry Date(s): | Date Created: 20240427 Date Completed: 20240529 Latest Revision: 20240529 |
| Update Code: | 20240530 |
| DOI: | 10.1016/j.imlet.2024.106860 |
| PMID: | 38677335 |
| ISSN: | 1879-0542 |
| DOI: | 10.1016/j.imlet.2024.106860 |
| Database: | MEDLINE |
Full Text via ClinicalKey